Sign in

You're signed outSign in or to get full access.

About John K. Nelson

Independent Board Member of Nuveen California AMT‑Free Quality Municipal Income Fund (NKX); born 1962; Class II trustee with current term expiring at the 2026 annual meeting; service on the Nuveen fund complex boards since 2013 . Former CEO of ABN AMRO Bank N.V. North America and Global Head of the Financial Markets Division; prior senior external advisor to Deloitte Consulting’s Financial Services practice; Fordham University BA (Economics) and MBA (Finance) . Deemed an Independent Board Member (not an “interested person” under the Investment Company Act) .

Past Roles

OrganizationRoleTenureCommittees/Impact
ABN AMRO Bank N.V. (incl. LaSalle Bank Corp.)CEO North America; Global Head, Financial Markets (FX, Commodities, Fixed Income, EM, Derivatives)1996–2008 (various leadership roles); Global Head 2007–2008Member, Federal Reserve FX Committee; representation on committees of Bank of Canada, ECB, Bank of England
Deloitte Consulting LLPSenior External Advisor, Financial Services2012–2014Strategy advisory to FS practice

External Roles

OrganizationRoleTenureNotes
Core12 LLC (private)Director2008–2023Branding/marketing/communications firm
Fordham UniversityMember, President’s Council2010–2019University advisory role
Fordham UniversityDirector, Curran Center for Catholic American Studies2009–2018Academic center governance
Marian UniversityTrustee and Chair, Board of Trustees2011–2013Board leadership

Board Governance

  • Independence: Not an “interested person” of the Funds, the Adviser, TIAA or Nuveen; all current trustees are Independent Board Members .
  • Committee leadership and memberships:
    • Audit Committee: Chair; designated “audit committee financial expert” .
    • Executive Committee: Member (with Board Chair Young, Kenny, Toth) .
    • Dividend Committee: Member .
    • Nominating & Governance Committee: Member .
    • Investment Committee: Member .
    • Closed‑End Fund Committee: Member .
  • Attendance: Each Board Member attended at least 75% of Board and committee meetings in the last fiscal year .
  • Meeting intensity (last fiscal year, NKX): 6 regular Board; 9 special Board; 3 Executive; 8 Dividend; 4 Compliance/Risk; 13 Audit; 6 Nominating & Governance; 3 Investment; 4 Closed‑End Funds .
  • Board Chair is independent (Robert L. Young), reinforcing board independence and agenda control .

Fixed Compensation

Compensation structure effective January 1, 2025 for Independent Board Members (allocated across the Nuveen fund complex):

ComponentAmount (USD)Notes
Annual Board Retainer$350,000All Independent Board Members
Audit Committee Membership$35,000Per member; chair receives an additional $35,000
Compliance/Risk Committee Membership$35,000Per member
Investment Committee Membership$30,000Per member; chair/co‑chair $30,000
Dividend Committee Membership$25,000Per member
Nominating & Governance Committee Membership$25,000Per member
Closed‑End Funds Committee Membership$25,000Per member
Board Chair Premium (not applicable to Nelson)$150,000Independent Chair only
Ad hoc meeting fees$1,000 or $2,500Based on length/immediacy
Special assignment committeesChair/Co‑Chair: from $1,250/quarter; Members: from $5,000/quarterAs constituted

Actual paid compensation (latest fiscal year):

  • Aggregate compensation paid by NKX to Nelson: $2,792 .
  • Total compensation paid from all Nuveen funds to Nelson: $483,250 (includes allocations and any deferred amounts) .

Deferred compensation plan is available; amounts are credited to a book reserve account mirroring chosen Nuveen fund investments; distributions can be lump sum or 2–20 years; Funds have no retirement or pension plans .

Performance Compensation

  • No performance‑based cash bonus, stock awards, options, or ESG/TSR/financial metric‑linked compensation disclosed for Independent Board Members .
  • Deferred compensation (participating funds) reported for Nelson: $0 in the disclosed table, indicating no current deferral balance in participating funds as of the report .

Other Directorships & Interlocks

Company/InstitutionTypeRolePotential Interlock/Conflict Considerations
Core12 LLCPrivate companyDirector (2008–2023)No disclosed transactions with Nuveen funds; limited conflict risk
Fordham University (President’s Council)Non‑profit/academicMember (2010–2019)No fund‑related dealings disclosed
Curran Center for Catholic American StudiesAcademicDirector (2009–2018)No fund‑related dealings disclosed
Marian UniversityAcademicTrustee & Chair (2011–2013)No fund‑related dealings disclosed

No related‑party transactions concerning Nelson are disclosed; Section 16(a) filings were compliant across trustees and officers in the last fiscal year .

Expertise & Qualifications

  • Deep global markets and banking leadership (FX, commodities, fixed income, derivatives, EM) from ABN AMRO/LaSalle, including risk oversight and financial controls experience .
  • Audit Committee Financial Expert designation and current Audit Committee Chair for the Funds .
  • Academic credentials: BA Economics and MBA Finance, Fordham University .

Equity Ownership

MeasureNKXFund Complex Aggregate
Shares beneficially owned0 Dollar range “Over $100,000” across all registered investment companies overseen (aggregate)
Ownership % of shares outstanding<1% for each fund, trustee levelEach trustee’s holdings <1% of each fund’s outstanding shares
Deferred compensation balance (participating funds)$0Reported $0 deferrals for Nelson in the participating funds table
Pledged sharesNone disclosedNone disclosed

Stock ownership governance principle: Trustees are expected to invest at least one year of compensation in Nuveen funds, directly or on a deferred basis; beneficial ownership per‑fund is $0 for NKX, aggregate is “Over $100,000,” and disclosed deferrals for Nelson show $0, which may indicate a shortfall versus the guideline absent other holdings not itemized beyond the aggregate range .

Governance Assessment

  • Strengths:

    • Independent director with extensive financial markets and risk oversight background; serves as Audit Committee Chair and SEC‑defined Financial Expert, supporting financial reporting quality and valuation oversight .
    • Broad committee engagement (Audit, Executive, Dividend, Nominating & Governance, Investment, Closed‑End), providing comprehensive governance touchpoints across risk, performance, and shareholder distribution policies .
    • Attendance at or above the 75% threshold, consistent with engaged oversight; high meeting cadence at NKX (13 Audit; 6 N&G; multiple Board/committee meetings) demonstrates active governance workload .
  • Potential alignment concerns:

    • NKX specific beneficial ownership is $0 and aggregate fund complex holdings reported only as “Over $100,000,” while the board’s principle expects at least one year’s compensation invested (Nelson’s total compensation $483,250); disclosed deferral balance is $0, suggesting lower visible alignment relative to the guideline unless other unlisted holdings satisfy the expectation (disclosure is aggregate by range, not precise) .
    • No related‑party or interlock conflicts disclosed for Nelson; overall low direct conflict risk; the proxy highlights one trustee’s external private investment interests (Kenny), but none for Nelson .
  • Signals for investors:

    • Audit chairmanship and expert designation are positive governance signals for financial reporting integrity and valuation oversight in a leverage‑using closed‑end fund structure .
    • Visible alignment could be strengthened by higher disclosed direct/deferred holdings consistent with the board’s investment principle; current reporting is limited to range data and shows $0 in NKX .

Board Governance (Detail Table)

CommitteeRoleKey Oversight
AuditChair; Financial ExpertFinancial reporting, auditor oversight, valuation policy and designee oversight
ExecutiveMemberActs with full Board authority between meetings
DividendMemberDeclares distributions (ratified by Board)
Compliance, Risk Mgmt & Regulatory OversightNot listed as memberOversight of compliance and enterprise/product risks (liquidity, leverage, derivatives)
Nominating & GovernanceMemberBoard composition, evaluations, governance guidelines, director compensation reviews
InvestmentMemberPerformance oversight, investment risk review, leverage/hedging assessments
Closed‑End FundsMemberPremium/discounts, leverage, market dynamics, repurchases/issuance reviews

Director Compensation (Detail Table)

ItemAmountSource
NKX aggregate compensation to Nelson (latest FY)$2,792
Total compensation from all Nuveen funds to Nelson (latest FY)$483,250
Deferred compensation plan availabilityYes; book account mirrors Nuveen fund investments; no pensions
Nelson deferred compensation balance (participating funds table)$0

Insider Filings and Compliance

  • Section 16(a) and 30(h) filings: Funds report full compliance by trustees and officers in the last fiscal year; no delinquent reports noted .

RED FLAGS

  • Low disclosed NKX ownership (0 shares) and only “Over $100,000” aggregate range versus one‑year compensation expectation; no current deferred compensation balance disclosed for Nelson, which may be viewed as weaker ownership alignment pending fuller holdings detail .
  • No related‑party transactions or tax gross‑ups, option repricing, or other compensation anomalies disclosed for Nelson; no legal proceedings indicated in proxy materials .